866-997-4948(US-Canada Toll Free)

Seasonal Influenza Global Clinical Trials Review, H2, 2018

Published By :

GlobalData

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 151 Pages

Seasonal Influenza Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, Seasonal Influenza Global Clinical Trials Review, H2, 2018" provides an overview of Seasonal Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Influenza. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Seasonal Influenza to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Seasonal Influenza to Infectious Disease Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Seasonal Influenza Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Seasonal Influenza 37
May 31, 2018: Windtree Therapeutics Aerosolized KL4 Surfactant Preclinical Data in Influenza Presented at the 2018 American Thoracic Society Meeting 37
May 18, 2018: Eurocine Vaccines has Completed Dosing of its Quadrivalent Influenza Vaccine Candidate, Immunose FLU, in the Second Clinical Study 37
May 10, 2018: SLU Studies Universal Flu Vaccine 37
May 08, 2018: US Health Authorities Turn To Israeli Universal Flu Vaccine Maker To Ward Off Next Influenza Outbreak 38
May 07, 2018: Baylor to participate in NIH trial for universal flu vaccine 39
May 04, 2018: NIAID-Sponsored Trial of a Universal Influenza Vaccine Begins 39
Clinical Trial Profile Snapshots 40
Appendix 149
Abbreviations 149
Definitions 149
Research Methodology 150
Secondary Research 150
About GlobalData 151
Contact Us 151
Disclaimer 151
Source 151

List of Tables
Seasonal Influenza Therapeutics, Global, Clinical Trials by Region, 2018* 7
Seasonal Influenza Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Seasonal Influenza Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Seasonal Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Seasonal Influenza Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Seasonal Influenza Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Seasonal Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Seasonal Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Seasonal Influenza to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 17
Seasonal Influenza Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Seasonal Influenza Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Seasonal Influenza to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 22
Seasonal Influenza Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Seasonal Influenza Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Seasonal Influenza Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Seasonal Influenza Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Seasonal Influenza Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Seasonal Influenza Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Seasonal Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Seasonal Influenza Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
Seasonal Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Seasonal Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Seasonal Influenza Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures
Seasonal Influenza Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Seasonal Influenza Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Seasonal Influenza Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Seasonal Influenza Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Seasonal Influenza Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Seasonal Influenza Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Seasonal Influenza Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Seasonal Influenza Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Seasonal Influenza to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
Seasonal Influenza Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Seasonal Influenza Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Seasonal Influenza to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 21
Seasonal Influenza Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Seasonal Influenza Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Seasonal Influenza Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Seasonal Influenza Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Seasonal Influenza Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Seasonal Influenza Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Seasonal Influenza Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Seasonal Influenza Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
Seasonal Influenza Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Seasonal Influenza Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Seasonal Influenza Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
GlobalData Methodology 150

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *